Scientists at Medicinal Genomics have published a peer-reviewed, highly-contiguous reference genome for the psychedelic mushroom species Psilocybe cubensis.
Taking psilocybin can affect one’s emotional state when listening to music, according to new research presented earlier this month.
To address this, two British ambulance services are now participating in a new trial to investigate whether ketamine injections may be a more effective relief treatment for severe injury pain than the current treatment options available to Britain’s first responders.
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
Recruitment is now underway for a first-of-its-kind study investigating the potential of ketamine to fight gambling addiction.
The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
The researchers from the University of Basel concluded that LSD caused no acute psychological or physical harm to the participants.
Gül Dölen, an associate professor of neuroscience at Johns Hopkins University, explained to Analytical Cannabis just how MDMA-assisted psychotherapy can reopen a “critical period” in the brain for social reward learning.